Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77,331,078
-
Total 13F shares
-
9,321,689
-
Share change
-
-603,486
-
Total reported value
-
$27,499,000
-
Price per share
-
$2.95
-
Number of holders
-
30
-
Value change
-
-$1,982,221
-
Number of buys
-
8
-
Number of sells
-
14
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q3 2017
As of 30 Sep 2017 Xenon Pharmaceuticals Inc. - Common Stock (XENE) had 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,321,689 shares of stock of the company.
Largest 10 holders included BVF INC/IL, Capital World Investors, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., DAFNA Capital Management LLC, Invesco Private Capital, Inc., Tekla Capital Management LLC, Point72 Asset Management, L.P., SABBY MANAGEMENT, LLC, and Schonfeld Strategic Advisors LLC.
This table shows 31 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.